182 related articles for article (PubMed ID: 25058589)
1. Correlation between EGFR amplification and the expression of microRNA-200c in primary glioblastoma multiforme.
Serna E; Lopez-Gines C; Monleon D; Muñoz-Hidalgo L; Callaghan RC; Gil-Benso R; Martinetto H; Gregori-Romero A; Gonzalez-Darder J; Cerda-Nicolas M
PLoS One; 2014; 9(7):e102927. PubMed ID: 25058589
[TBL] [Abstract][Full Text] [Related]
2. The Status of
Muñoz-Hidalgo L; San-Miguel T; Megías J; Serna E; Calabuig-Fariñas S; Monleón D; Gil-Benso R; Cerdá-Nicolás M; López-Ginés C
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396457
[TBL] [Abstract][Full Text] [Related]
3. New pattern of EGFR amplification in glioblastoma and the relationship of gene copy number with gene expression profile.
Lopez-Gines C; Gil-Benso R; Ferrer-Luna R; Benito R; Serna E; Gonzalez-Darder J; Quilis V; Monleon D; Celda B; Cerdá-Nicolas M
Mod Pathol; 2010 Jun; 23(6):856-65. PubMed ID: 20305620
[TBL] [Abstract][Full Text] [Related]
4. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
[TBL] [Abstract][Full Text] [Related]
5. Expression level of microRNA-200c is associated with cell morphology in vitro and histological differentiation through regulation of ZEB1/2 and E-cadherin in gastric carcinoma.
Kurata A; Yamada M; Ohno SI; Inoue S; Hashimoto H; Fujita K; Takanashi M; Kuroda M
Oncol Rep; 2018 Jan; 39(1):91-100. PubMed ID: 29138864
[TBL] [Abstract][Full Text] [Related]
6. Cellular heterogeneity contributes to subtype-specific expression of ZEB1 in human glioblastoma.
Euskirchen P; Radke J; Schmidt MS; Schulze Heuling E; Kadikowski E; Maricos M; Knab F; Grittner U; Zerbe N; Czabanka M; Dieterich C; Miletic H; Mørk S; Koch A; Endres M; Harms C
PLoS One; 2017; 12(9):e0185376. PubMed ID: 28945795
[TBL] [Abstract][Full Text] [Related]
7. Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry.
Lee M; Kang SY; Suh YL
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):589-598. PubMed ID: 29912767
[TBL] [Abstract][Full Text] [Related]
8. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
[TBL] [Abstract][Full Text] [Related]
9. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR‑205 is associated with glioblastoma cell migration, invasion, and the epithelial-mesenchymal transition, by targeting ZEB1 via the Akt/mTOR signaling pathway.
Chen W; Kong KK; Xu XK; Chen C; Li H; Wang FY; Peng XF; Zhang Z; Li P; Li JL; Li FC
Int J Oncol; 2018 Feb; 52(2):485-495. PubMed ID: 29345288
[TBL] [Abstract][Full Text] [Related]
11. Magnolol regulates miR-200c-3p to inhibit epithelial-mesenchymal transition and retinoblastoma progression by modulating the ZEB1/E-cadherin axis in vitro and in vivo.
Lai YH; Liu WL; Lee TY; Kuo CW; Liu YR; Huang CY; Chen YH; Chen IL; Wu SH; Wang SC; Lee PY; Liu CC; Lo J; Chang YC; Kuo HF; Hsieh CC; Li CY; Liu PL
Phytomedicine; 2023 Feb; 110():154597. PubMed ID: 36603340
[TBL] [Abstract][Full Text] [Related]
12. Targets of miR-200c mediate suppression of cell motility and anoikis resistance.
Howe EN; Cochrane DR; Richer JK
Breast Cancer Res; 2011 Apr; 13(2):R45. PubMed ID: 21501518
[TBL] [Abstract][Full Text] [Related]
13. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Yoshida T; Song L; Bai Y; Kinose F; Li J; Ohaegbulam KC; Muñoz-Antonia T; Qu X; Eschrich S; Uramoto H; Tanaka F; Nasarre P; Gemmill RM; Roche J; Drabkin HA; Haura EB
PLoS One; 2016; 11(1):e0147344. PubMed ID: 26789630
[TBL] [Abstract][Full Text] [Related]
14. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma.
Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N
Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572
[TBL] [Abstract][Full Text] [Related]
15. The role of microRNA-200 in progression of human colorectal and breast cancer.
Bojmar L; Karlsson E; Ellegård S; Olsson H; Björnsson B; Hallböök O; Larsson M; Stål O; Sandström P
PLoS One; 2013; 8(12):e84815. PubMed ID: 24376848
[TBL] [Abstract][Full Text] [Related]
16. Concurrent EGFR amplification and TP-53 mutation in glioblastomas.
Gil-Benso R; Lopez-Gines C; Benito R; López-Guerrero JA; Callaghan RC; Pellín A; Roldán P; Cerdá-Nicolas M
Clin Neuropathol; 2007; 26(5):224-31. PubMed ID: 17907599
[TBL] [Abstract][Full Text] [Related]
17. Frequency of NFKBIA deletions is low in glioblastomas and skewed in glioblastoma neurospheres.
Patanè M; Porrati P; Bottega E; Morosini S; Cantini G; Girgenti V; Rizzo A; Eoli M; Pollo B; Sciacca FL; Pellegatta S; Finocchiaro G
Mol Cancer; 2013 Dec; 12():160. PubMed ID: 24330732
[TBL] [Abstract][Full Text] [Related]
18. MiRNA-200C expression in Fanconi anemia pathway functionally deficient lung cancers.
Duan W; Tang S; Gao L; Dotts K; Fink A; Kalvala A; Aguila B; Wang QE; Villalona-Calero MA
Sci Rep; 2021 Feb; 11(1):4420. PubMed ID: 33627769
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of the microRNA hsa-miR-200c leads to reduced expression of transcription factor 8 and increased expression of E-cadherin.
Hurteau GJ; Carlson JA; Spivack SD; Brock GJ
Cancer Res; 2007 Sep; 67(17):7972-6. PubMed ID: 17804704
[TBL] [Abstract][Full Text] [Related]
20. miRNA-200c increases the sensitivity of breast cancer cells to doxorubicin through the suppression of E-cadherin-mediated PTEN/Akt signaling.
Chen Y; Sun Y; Chen L; Xu X; Zhang X; Wang B; Min L; Liu W
Mol Med Rep; 2013 May; 7(5):1579-84. PubMed ID: 23546450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
